Palifermin After Haploidentical PBSCT
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
The Role of Erlotinib an Epidermal Growth Factor Receptor (EGFR) Inhibitor in the Treatment of Myelodysplastic Syndrome
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)
- Status
- UNKNOWN
- Phase
- N/A
Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant
- Status
- COMPLETED
- Phase
- N/A
Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)
- Status
- TERMINATED
- Phase
- PHASE2
Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients
- Status
- COMPLETED
- Phase
- N/A
Cord Blood Expansion on Mesenchymal Stem Cells
- Status
- COMPLETED
- Phase
- PHASE1
SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Treosulfan-based Conditioning for Transplantation in AML/MDS
- Status
- COMPLETED
- Phase
- PHASE2
Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE4
SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS
- Status
- TERMINATED
- Phase
- PHASE2